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Background: Plasmodium ovale and Plasmodium malariae infections are scarcely studied in sub-Saharan
Africa, where the Plasmodium falciparum species predominates. The objective of this study is to investigate
the prevalence of P. ovale and P. malariae infections and their relationship with common red blood cell poly-
morphisms in a cohort of 509 individuals from Uganda.
Methods: Three cross-sectional surveys were conducted in individuals of 1–10 and >20 y of age from the
Apac district at baseline and 6 and 16 weeks after drug treatment. Malaria infections were assessed by poly-
merase chain reaction and genotyping was performed for the sickle cell allele, α-thalassaemia and glucose-
6-phosphate dehydrogenase.
Results: At baseline, the prevalence of infection was 7.5%, 12.6% and 57.4% for P. ovale, P. malariae and P. fal-
ciparum species, respectively. Co-infections were present in 14.1% of individuals, all including P. falciparum
parasites. In children 1–5 y of age, the prevalence of P. ovale mono-infections increased significantly from
1.7% to 7.3% over time (p=0.004) while the prevalence of P. malariae and P. falciparum infections declined sig-
nificantly during this study. After adjusting for confounding and multiple testing, only α-thalassaemia had a
statistically significant increase in the odds of P. falciparum infections (odds ratio 1.93 [95% confidence inter-
val 1.26 to 2.94]).
Conclusions: Common red blood cell polymorphisms do not show strong effects on mild Plasmodium infec-
tions in this Ugandan population. To understand the extent of this result, similar studies should be carried out
in other populations using larger cohorts.
Keywords: ACT, co-infections, genetic association, non-falciparum
Introduction
In the last decade, the burden of Plasmodium falciparum has
decreased in Africa.1,2 Less is known about the burden of the
sympatric and often-neglected malaria species Plasmodium
ovale and Plasmodium malariae. Several studies have reported
low prevalence and incidence rates of these species in Africa.3–8
However, their prevalence may have been underestimated in
studies relying on rapid diagnostic tests (RDTs) detecting the
histidine-rich protein 2, which is not expressed by P. malariae
and P. ovale parasites.9 Additionally, infections with P. malariae
and P. ovale are typically asymptomatic and with low parasit-
aemia.10,11 The quiescent hypnozoite stage also diminishes the
detectability of P. ovale infections.10 In line with a likely
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underestimation of these non-falciparum infections, a recent
serological study showed a high seroprevalence associated with
antigens of these malaria species in Benin.12 Clearly, more epi-
demiological investigations are needed to quantify the real con-
tribution of these neglected species to the total burden of
malaria in Africa. Molecular methods can improve the detect-
ability of malaria infections and allow the distinction between
different malaria species.13
Until now only a few studies have attempted to assess the
variation of P. falciparum, P. ovale and P. malariae infections over
time.3,4 A landmark study is the 20-y follow-up of the Dielmo
community from Senegal.14 In this community, the prevalence
of each malaria species remained high until 2004, when it
began to decrease until reaching very low levels in 2010.4,15
This decrease was attributed to changes in antimalarial drug
policies in 2010 when treatment policy shifted to an
artemisinin-based combination therapy (ACT). In Mozambique,
it was reported that the prevalence of P. malariae and P. ovale
infections decreased substantially during the wet season with a
concomitant increase of P. falciparum mono-infections.16 This
observation suggests a seasonal change in the composition of
the Plasmodium pool circulating in the population.16–18
Genetic factors might play an important role in the acquisi-
tion and clearance of malaria infections and the likelihood of
these progressing to clinical disease. In sub-Saharan African,
common red blood cell (RBC) polymorphisms, including the
sickle cell allele and thalassaemia, have been associated with
protection against severe forms of P. falciparum malaria.19–21
Although less convincing, there is also evidence that these gen-
etic variants have an impact on P. falciparum asymptomatic
malaria and parasite density.22–24 Little is known about whether
these associations can be extended to P. ovale and P. malariae
infections. Since morbidity and mortality are generally low in
non-falciparum infections, it is expected that the respective
selective pressure is less strong than that derived from P. falcip-
arum alone. On the other hand, the likelihood of generating
mixed infections in the same individual might trigger pleiotropic
effects of existing genetic variants on the control of these
infections.
To fill in some of the research gaps concerning P. falciparum,
P. ovale and P. malariae infections, this study aims to assess the
prevalence of these malaria species and their dynamics after
antimalarial treatment in a cohort living in a high-transmission
area of Uganda and their association with common RBC
polymorphisms.
Methods
Study design
The study was conducted between July and November 2010 in
Abedi parish in the Apac district, a highly endemic area of
Uganda with perennial transmission.25 Briefly, the study partici-
pants were recruited using predefined strata (1–5 y, n=249;
6–10 y, n=126; >20 y, n=134). The recruitment was based on a
random selection of all households that could be mapped
within a 5-km radius of the Abedi Health Centre. Households
with at least one child from the lowest age stratum and at least
one individual from one of the other age strata were considered
eligible for participation. The exclusion criteria were a weight‐
for‐height or height‐for‐age Z‐score <−3, severe anaemia
(haemoglobin <5.0 g/dL) or the presence of any chronic disease.
Excluded individuals were referred to the Apac District Hospital
for appropriate clinical management. Additional information
about the sampling can be found in the original reference to
this study.25
Blood samples were taken from the participants by finger-
prick at baseline (July 2010) and after 6 and 16 weeks (August
and November 2010, respectively), coinciding with the peak
time of malaria transmission. Samples were collected into ethy-
lenediaminetetraacetic acid–coated microtainers and blotted
onto filter papers (3mm; Whatman, Maidstone, UK). Passive
case detection was implemented, with dedicated study staff at
the health facility being available 24 h per day throughout the
week. At baseline, all study participants received ACT treatment
with artemether–lumefantrine due to previously published evi-
dence of submicroscopic infections in the population.26 Indoor
residual spraying (IRS) in the population was conducted a
month after the second survey as part of the national malaria
control program. The precise dates of spraying were neither
monitored nor recorded by the research team from this study.
Molecular analysis and parasite detection
Malaria infection was detected using molecular assays. DNA
was first extracted from filter papers using the QIAamp mini kit
(QIAGEN, Venlo, The Netherlands). Plasmodium species detection
was then done by nested polymerase chain reaction (PCR) amp-
lification of the small subunit (18S) ribosomal RNA gene.13
Parasite density was estimated in P. falciparum infections only
using microscopy.
Sample genotyping
Human DNA was first extracted from blood samples and then
used for genotyping of the sickle haemoglobin gene (HbS) using
methods described in detail elsewhere.27 Glucose-6-phosphate
dehydrogenase (G6PD) deficiency status was determined by
genotyping the single-nucleotide polymorphism resulting in
G202A in the G6PD gene.28 The status of α-thalassemia was
determined in each participant by assessing the African α-globin
deletion α3.7.29
Statistical analysis
To investigate the association between P. falciparum, P. ovale
and P. malariae infections, three-way contingency tables were
first constructed for each age group. As a null hypothesis,
mutual independence (i.e. the infection status of each malaria
species is independent of the remaining ones) was tested in
these tables using an appropriate log-linear model. The respect-
ive model estimation was performed using the maximum likeli-
hood (ML) method. Likelihood ratios and Pearson’s tests were
used to assess the goodness-of-fit of the estimated models. In
these tests, p-values >0.05 provided evidence for the hypothesis
of mutual independence. The Cochran–Armitage test for trend
was also used to explore the dynamics of prevalence over time.
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For each malaria species, the ratios between probabilities of
infection status referring to different time points were estimated
using an appropriate log-linear model for categorical variables.
The study of the genetic association was performed using
baseline data only, because both treatment at baseline and
indoor spraying that occurred afterwards could mask the puta-
tive genetic associations. Since there were missing genotypes
due to either sample exhaustion or amplification failures, a stat-
istical analysis was performed on these data to understand
their potential source of bias. An association between the miss-
ing status of each genetic polymorphism and different possible
covariates (e.g. infection status of each malaria species or age
strata) was performed using a Pearson’s χ2 test for independ-
ence in two-way contingency tables where p-values >0.05 were
indicative of no association between a given covariate and the
missing genotype status under analysis. In addition, a missing
completely at random (MCAR) model30 was fitted to the three-
way contingency table referring to the cross-tabulation of the
three genetic polymorphisms, including the missing genotype
frequencies (Supplementary Table 1). The estimation step was
done via the ML method, while the respective goodness-of-fit
was assessed by a likelihood ratio test where a p-value >0.05
suggested evidence for the MCAR.
For the data referring to fever and infection status for each
malaria species, genetic associations were initially assessed with a
univariate analysis using the Freeman–Halton exact test for inde-
pendence in two-way contingency tables, where p-values <0.05
were indicative of a possible association (unadjusted analysis). This
exact test was used due to the unbalanced nature of the fre-
quency tables under analysis, where use of the traditional χ2 test
is not recommended. The unadjusted analysis was then extended
to adjust for age and gender and to include different single-locus
genetic effects. In particular, a (non-genetic) logistic regression
model including gender and age strata was fitted to data of infec-
tion status for each Plasmodium species. Genetic logistic models
including the above covariates and the genetic effect under test-
ing were also fitted to the same data. The genetic effects under
testing were defined in terms of the alternative allele and describ-
ing the following modes of inheritance: general—each genotype
has its own effect; additive—the effect of the allele is additive;
dominant—the effect of the homozygotic and heterozygotic geno-
types are the same; heterosis—the effect of both homozygotic
genotypes is the same.27,31 In this analysis, evidence for a genetic
association was assessed using a likelihood ratio test where the
non-genetic model was compared with each genetic model
(adjusted analysis).
Similar association analysis was conducted for the parasite
density (on a logarithmic scale) in data from individuals with
evidence of a P. falciparum infection. Since this quantitative trait
followed an approximate Gaussian distribution, the unadjusted
analysis was performed using analysis of variance tests. The
adjusted analysis was performed as described above but using
linear regression models.
Since there were three RBC polymorphisms for each pheno-
type, a Bonferroni correction was used for controlling for mul-
tiple testing, which ensured a global 5% significance level for
the association analysis. Note that for the association analysis
of a given trait and genetic variant, testing five different modes
of inheritance is equivalent to selecting the ‘best’ model for the
corresponding data and, as such, it was not accounted for
when correcting for multiple testing.
Data were analysed in using Stata version 13 (StataCorp,
College Station, TX, USA) and R software version 3.3.2 (http://
www.r-project.org). In particular, the package ACD/CatData for
the R software (http://CRAN.R-project.org/package=ACD) was
used to analyse all categorical variables, including their missing
data patterns. The analysis scripts are available from the corre-
sponding author upon request.
Results
Baseline characteristics of the study participants
A total of 509 individuals were recruited in the following three
age strata: 1–5 y (n=249), 6–10 y (n=126) and >20 y (n=134)
(Table 1); 52.5% of the cohort participants were female and
65.2% owned a bed net. As expected, RBC polymorphisms were
common in this survey: 14.6% (67/460) were carriers of the
G6PD-defficiency allele, 20.2% (89/441) were carriers of the
HbS allele and 45.7% (221/483) were α-thalassemia carriers
(Table 1). Twenty-four individuals were both α-thalassemia and
sickle cell carriers, 17 had both a homo-/heterozygous α-thalas-
semia allele and heterozygous G6PD-deficient allele and 7 had
both a homo-/heterozygous α-thalassemia trait and homozy-
gous G6PD-deficient allele. The co-existence of a homo-/hetero-
zygous G6PD-deficient allele with a homo-/heterozygous sickle
cell allele was rare in the participants. Three individuals of 6, 40
and 46 y of age were carriers of all three haemoglobinopathies.
From the initial sample size of 509, there were only 391 indivi-
duals with complete genotype data, while the remaining indivi-
duals had at least one missing genotype (Supplementary
Table 1). Five individuals had no data available on the three gen-
etic polymorphisms under analysis.
To assess any potential source of bias due to missing data, a
statistical analysis was performed where the association between
different covariates and the missing genotype status was tested
(Supplementary Figure 1). There was strong evidence for no asso-
ciation between the missing genotype status and most of the cov-
ariates, including infection status for each malaria species. Gender
and age group seemed borderline associated with the missing
data status of HbS and α-thalassaemia genes. Finally, when ana-
lysing Supplementary Table 1, the expected frequencies under an
MCAR mechanism were in good agreement with the observed
data (likelihood ratio test, p=0.93 with 23 degrees of freedom;
Supplementary Table 1). Therefore there was strong evidence that
the missing genotypes were generated completely at random.
According to this mechanism, the corresponding adjusted percen-
tages of HbS, α-thalassaemia and G6PD carriers were estimated
at 20.2%, 37.2% and 18.6%, respectively.
Analysis of the prevalence of infections over time
Overall, the prevalence of any Plasmodium infection detected by
PCR was 58.9% at baseline (Table 1). The percentages of P. fal-
ciparum, P. malariae and P. ovale infections were 57.4% (95%
confidence interval [CI] 53.0 to 61.7), 12.7% (95% CI 9.6 to
15.8) and 7.5% (95% CI 5.2 to 9.8), respectively. Non-falciparum
mono-infections (P. malariae or P. ovale) and mixed infections
Transactions of the Royal Society of Tropical Medicine and Hygiene
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accounted for 3.3% (95% CI 1.6 to 4.9) and 14.2% (95% CI 11.2
to 17.7) of the total infections; co-infections were estimated at
8.8% (95% CI 6.1 to 11.4) for P. falciparum/P. malariae, 3.2%
(95% CI 1.5 to 4.8) for P. falciparum/P. ovale and 2.3% (95% CI
0.9 to 3.6) P. falciparum/P. malariae/P. ovale. All of these mixed-
species infections included P. falciparum.
To understand the association between different malaria
species, a hypothesis of mutual independence was tested on
data from each age group. Evidence for this hypothesis was
found for the 6–10 y and >20 y age groups (p-values >0.1, likeli-
hood ratio test). Infections of different malaria species appear
to be associated with each other in the 1–5 y age group
(p<0.001, likelihood ratio test).
After curative treatment, the prevalence of P. falciparum
infections decreased in every age group (Figure 1A–C). Moreover,
the overall probability of being P. falciparum–infected decreased
29.1% (95% CI 19.6 to 37.4) and 69.0% (95% CI 61.8 to 74.9)
at weeks 6 and 16, respectively, in relation to baseline
(Figure 1D; see Supplementary Table 2 for detailed data on the
respective infection dynamic profiles). A similar decrease over
time was observed for P. malariae infections in all age groups. In
contrast, the prevalence of P. ovale infections increased from
baseline to week 6 in both the 1–5 y and 6–10 y age groups
(Figure 1A and B). However, statistical significance was only
reached in the youngest age group (Figure 1D). In this age
group, the probability of being P. ovale infected increased 94.4%
Table 1. Baseline characteristics of study participants and the respective prevalence of Plasmodium infection by age group
Characteristics 1–5 y of age 6–10 y of age ≥20 y of age Overall
Female 125/249 (50.2) 55/126 (43.7) 87/134 (64.9) 267/509 (52.5)
Low haemoglobin counta 97/249 (39.0) 19/126 (15.1) 9/134 (6.7) 125/509 (24.6)
Feverb 25/247 (10.1) 7/125 (5.6) 10/134 (7.5) 42/506 (6.1)
P. falciparum parasite density, median
(minimum–maximum)c
1200 (80–147 200) 480 (40–19 440) 200.0 (40–760) 760 (40–147 200)
Bed net ownership 183/248 (73.8) 57/123 (46.3) 89/134 (66.4) 329/505 (65.2)
G6PD status
Wild-type 198/231(85.7) 96/113 (85.0) 99/116 (85.3) 393/460 (85.4)
Heterozygous 22/231 (9.5) 8/113 (7.1) 13/116 (11.2) 43/460 (9.4)
Homo-/heterozygous 11/231 (4.8) 9/113 (8.0) 4/116 (3.5) 24/460 (5.2)
Sickle cell allele status
Wild-type 186/224 (83.0) 83/110 (75.5) 83/107 (77.6) 352/441 (79.8)
Heterozygous 37/224 (16.5) 27/110 (24.6) 24/107 (22.4) 88/441 (20.0)
Homozygous 1/224 (0.5) 0/110 (0.0) 0/107 (0.0) 1/441 (0.2)
α-Thalassaemia status
Wild-type 134/242 (55.4) 71/123 (57.7) 67/118 (56.8) 272/483 (56.3)
Heterozygous 90/242 (37.2) 46/123 (37.4) 44/118 (37.3) 180/483 (37.3)
Homozygous 18/242 (7.4) 6/123 (4.9) 7/118 (5.9) 31/483(6.4)
Plasmodium infection
Overall 141/248 (56.9) 107/126 (84.9) 51/134 (38.1) 299/508 (58.9)
P. falciparum 130/240 (54.2) 103/122 (84.4) 48/128 (37.5) 281/490 (57.4)
P. malariae 30/234 (12.8) 25/102 (24.5) 3/121 (2.5) 58/457 (12.7)
P. ovale 20/248 (8.1) 15/126 (11.9) 3/134 (2.2) 38/508 (7.5)
Mono-infection
P. falciparum 93/229 (40.6) 55/100 (55.0) 40/115 (21.3) 188/444 (42.3)
P. malariae 5/229 (2.2) 1/100 (1.0) 1/115 (0.9) 7/444 (1.6)
P. ovale 3/229 (1.3) 3/100 (3.0) 2/115 (1.7) 8/444 (1.8)
Co-infection
P. falciparum+P. malariae 18/229 (7.9) 19/100 (19.0) 2/115 (1.7) 39/444 (8.8)
P. falciparum+P. ovale 9/229 (3.9) 5/100 (5.0) 0/115 (0.0) 14/444 (3.2)
P. malariae+P. ovale 0/229 (0.0) 0/100 (0.0) 0/115 (0.0) 0/444 (0.0)
P. falciparum+P. ovale+P. malariae 5/229 (2.2) 5/100 (5.0) 0/115 (0.0) 10/444 (2.3)
Values are presented as n/N (%) unless stated otherwise.
aHaemoglobin <11 g/dL.
bFever ≥37.5°C.
cFor P. falciparum–infected individuals only.
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(95% CI 16.5 to 224.5) in relation to baseline (with a 8.1%
prevalence of infections).
Association between haemoglobinopathies and
Plasmodium infections
Simple univariate analyses detected two putative associations
of α-thalassaemia and the G6PD gene with P. falciparum infec-
tions at baseline (Pearson’s χ2 test, p-value >0.01–<0.05;
Figure 2A). When these associations were adjusted for gender
and age and tested using different genetic effects, only the asso-
ciation referring to α-thalassaemia remained significant accord-
ing to the Bonferroni correction (Figure 2B and Supplementary
Figure 2). The best genetic model—heterosis effect—predicted an
increased risk of P. falciparum infections in heterozygotic carriers
of the α-thalassaemia allele (adjusted odds ratio [OR] 1.93 [95%
CI 1.26 to 2.94], p=0.002; Table 2).
The adjusted analysis also revealed a possible association
between the sickle cell allele and P. ovale infections (Figure 2B
and Supplementary Figure 2). The best model for this associ-
ation (including a heterosis effect) reached the 5% significance
level but did not hold when correcting for multiple testing. This
model predicted an increased risk of P. ovale infections in
heterozygotic carriers of the sickle cell allele (adjusted OR 2.37
[95% CI 1.10 to 5.09], p=0.027; Table 2).
Since the three genetic polymorphisms usually have a pro-
tective effect against complicated or severe forms of malaria,
the above association study was further extended to the ana-
lysis of fever and P. falciparum parasite density. There were only
42 individuals with fever (Table 1), of which 23 were infected
with P. falciparum and 4 with P. malariae. None of the febrile
cases were infected with P. ovale parasites. Thus the genetic
polymorphisms under analysis were not expected to be strongly
associated with fever. The respective association analysis
showed a borderline effect of the HbS allele on fever, which did
not reach statistical significance after adjusting for multiple
testing and confounding (Figure 3). No significant associations
were obtained for parasite density after conducting similar
adjustments (Figure 3). This finding is explained in part by a
strong effect of age on parasite density (Table 1), which reduces
the power to detect the effect of these genetic polymorphisms.
Discussion
This study investigated the dynamics of P. falciparum, P. malariae
and P. ovale infections and the possible role of common RBC
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Figure 1. Prevalence of
Q3
Plasmodium infection (overall, single or mixed P. falciparum, P. malariae and P. ovale) over time in different age groups:
(A) 1–5 y; (B) 6–10 y and (C) >20 y. (D) Ratios between the estimated probabilities of infections and their 95% CIs, where w6/w0 is the ratio of the
probability of infection at week 6 and baseline and w16/w0 is the ratio of the probability of infection at week 16 and baseline.
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polymorphisms in susceptibility to these infections in an area of
intense malaria transmission in northern Uganda. The results
provide evidence for a decline in the prevalence of P. falciparum
and P. malariae infections in all age groups after treatment with
ACT, followed by another decrease after community-based IRS.
Two comments can be made about these results. The first is
that although there was a decline in the prevalence of P. falcip-
arum infections, many study participants were infected at week
6. These infections might have resulted from either re-infection
or poor response to treatment. Re-infection would appear to be
the most reasonable explanation since the population under
study is located in an area of intense transmission intensity and
sampling coincided with the peak of transmission season. In
addition, poor response to treatment has not been reported in
the study area.
The second comment concerns the concomitant benefit of
ACT in clearing not only P. falciparum infections, but also P.
malariae infections. Similar results were observed in the village
of Dielmo, Senegal, where the shift to an ACT-based drug policy
led to near elimination of both P. falciparum and P. malariae in
the area.15 However, a recent study from Uganda reported an
increase in the prevalence of P. malariae infections in ACT-
treated children monitored for malaria and schistosomiasis dur-
ing an 18-month period in the village of Bukoba, Tanzania.32
This contrasting finding might be explained by reduced ACT
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Figure 2. Association analysis between infection status for Plasmodium
species (phenotype of interest) at baseline and common RBC poly-
morphisms (HbS: sickle cell gene; αT: α-thalassaemia gene; G6PD: G6PD-
deficiency gene). (A) Unadjusted analysis where the association between
each polymorphism and each phenotype of interest was assessed using
Pearson’s χ2 tests for independence. (B) Adjusted analysis where the
association between each polymorphism and each phenotype of inter-
est was assessed using the likelihood ratio tests. These tests refer to the
comparison between a ‘null’ model including gender and age as covari-
ates and different ‘genetic models’ that include gender, age and the
respective genetic effect being tested (general, dominant, additive,
recessive and heterosis). The strength of the association was measured
by −log10(p-value) (on the y-axis), where the lower and upper horizontal
dashed lines refer to the 5% significance level and the significance level
of each individual test that warrants a 5% global significance for the
analysis according to the Bonferroni correction.
Table 2. Adjusted ORs for the association between the α-
thalassaemia allele (αT) and P. falciparum infection and between
the sickle cell allele (HbS) and P. ovale infections according to the
best models (with heterosis effect) shown in Figure 2B
Association Predictor OR (95% CI) p-Value
αT/P.
falciparum
Age group (years)
1–5 1 –
6–10 4.60 (2.63 to 8.05) <0.001
>20 0.46 (0.28 to 0.74) <0.001
Gender (female) 0.72 (0.48 to 1.09) 0.118
αT (heterozygotic) 1.93 (1.26 to 2.94) 0.002
HbS/P. ovalea Age group (years)
1–5 1 –
6–10 1.60 (0.75 to 3.42) 0.229
>20 0.37 (0.11 to 1.32) 0.125
Gender (female) 0.45 (0.21 to 0.97) 0.041
HbS (heterozygotic) 2.37 (1.10 to 5.09) 0.027
aAssociation does not hold after using Bonferroni correction for
multiple testing (Figure 2B).
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Figure 3. Association analysis of common RBC polymorphisms with fever
and P. falciparum parasite density. HbS: sickle cell allele; αT: α-thalassae-
mia gene; G6PD: G6PD-deficiency gene. See Figure 2 for further details.
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efficacy due to a specific interaction with schistosomiasis drug
treatment given to all participants in this study. Unfortunately,
this possible explanation was not explored in the original study.
With respect to P. ovale infections, ACT would appear to pro-
duce similar qualitative benefits for older age groups. In con-
trast, the amount of single P. ovale infections significantly
increased over time in children 1–5 y old. The reason for this
increase is unclear but might be related to two alternative
hypotheses, as discussed for P. vivax infections after ACT in
Southeast Asia.33 The first hypothesis suggests that a high prob-
ability of co-infections might lead to suppression of P. ovale
parasitaemia by concurrent P. falciparum parasites, typically in
greater densities. The second hypothesis is that P. falciparum
infections and their subsequent treatment might have activated
dormant P. ovale hypnozoites. Unfortunately, there were no
available genetic data of the infecting parasites, so the validity
of this hypothesis could not be assessed.
There was evidence for an association between the preva-
lence of infection with different malaria species in children 1–5 y
of age. Such an association might be a consequence of non-
specific immune responses at these early ages. Consistent with
this explanation is the similar antibody levels against different
P. falciparum blood-stage antigens between infected and non-
infected children in a previous analysis of the same cohort.25 In
contrast, infections of different malaria species were found to
be mutually independent of each other in the remaining age
strata. This mutual independence agrees with an acquisition of
species-specific immunity due to continuous exposure to mal-
aria parasites in this highly endemic area of Uganda. This
acquired immunity is likely to be translated into an increase in
specific antibodies against P. ovale and P. malariae MSP1 anti-
gens with age, as shown in other populations where these mal-
aria species coexist.34,35
The overall prevalence of P. ovale infections was relatively
stable during the study period even in the presence of ACT cura-
tive treatment. The reason for this stability is unclear but might
be due to combinations of re-infections, recrudescences or
relapses. Again, genetic data of the infecting parasites could
have helped in distinguishing the contribution of these different
events in the infection profile of each individual. However, a
recent theoretical study on P. vivax/P. falciparum co-infection
dynamics showed that even when this type of data is available,
there is limited statistical power to classify a given infection as a
re-infection, recrudescence or relapse with a high probability.36
The prevalence of all Plasmodium species was highest
among children 6–10 y of age, as reported elsewhere.14,37 This
result is likely related to the development of immunity that lim-
its clinical symptoms but does not reduce the chance of being
infected. As expected, adults had the lowest prevalence of mal-
aria infections because of well-established malaria immunity
due to continuous parasite exposure.
Both α-thalassaemia and the HbS allele are typically in strong
association with severe malaria.38,39 In this study, the analysis
was focused on asymptomatic individuals where infection could
be detected using PCR. Therefore there was a prior expectation
that the association signals would be reduced when compared
with those derived from studies targeting symptomatic indivi-
duals. This expectation was confirmed with the detection of a
single positive association between α-thalassaemia carriage
and PCR-detected P. falciparum infection. Similar results were
observed in northeast Tanzania, where α-thalassaemia carriers
have a reduced risk of being infected.22 In terms of the mechan-
ism, the protection of α-thalassaemia against infection might
result from impaired growth of parasites in thalassaemic
RBCs.40 In contrast, the HbS allele was weakly associated with
the prevalence of P. ovale infections. This is not a surprising
result, because the underlying statistical power is likely to be
reduced owing to a low prevalence of non-falciparum infections.
For P. falciparum, the joint analysis of multiple survey points
could have allowed detection of the association signals related
to infection, as demonstrated in a study from Burkina Faso.23
Unfortunately, this type of analysis was not performed, as the
population under study experienced drug/IRS interventions after
baseline, thus masking possible effects of the RBC polymorph-
isms on infection.
In this study, there was no evidence of an association
between common RBC polymorphisms and P. falciparum para-
site density. This result is not surprising since the infected indivi-
duals were asymptomatic, with a few cases of non-malaria
fever. Unfortunately there were no data available about the
parasite density for non-falciparum infections. These hypothet-
ical data would have allowed us to investigate the pleiotropic
effects of RBC polymorphisms on parasitaemia of P. ovale and
P. malariae infections and on the relative contribution of each
malaria species to the overall parasitaemia in co-infections. This
study could have also benefited from a larger sample size that
would have increased the power to detect moderate associa-
tions between RBC polymorphisms and infection outcomes.
In conclusion, this study reported the prevalence dynamics
of P. ovale and P. malariae infections in a malaria hyperendemic
area in sub-Saharan Africa and a persistence of P. ovale infec-
tions over the malaria season. There was a possible protective
effect of α-thalassaemia against asymptomatic P. falciparum
infections. Another possible association was found between the
HbS allele and P. ovale infections, but it did not hold after adjust-
ing for confounding and multiple testing. The use of larger
cohorts would help to confirm these associations and detect
others with moderate effect. This study also showed that
P. malariae and P. ovale infections are both more common than
thought. Although not associated with severe disease, these
non-falciparum infections are likely to persist if interventions
only target P. falciparum parasites, thus slowing down elimin-
ation efforts in endemic areas where these infections co-exist.
Supplementary data Q2
Supplementary data are available at Transactions online (http://
trstmh.oxfordjournals.org/).
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